Catalytic site prediction and virtual screening of cytochrome P450 2D6 substrates by consideration of water and rescoring in automated docking

被引:116
作者
de Graaf, C
Oostenbrink, C
Keizers, PHJ
van der Wijst, T
Jongejan, A
Vemleulen, NPE
机构
[1] Free Univ Amsterdam, Div Mol Toxicol, Leiden Amsterdam Ctr Drug Res, NL-1081 HV Amsterdam, Netherlands
[2] Free Univ Amsterdam, Div Pharmaceut Sci, Dept Chem & Pharmacochem, NL-1081 HV Amsterdam, Netherlands
关键词
D O I
10.1021/jm0508538
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Automated docking strategies successfully applied to binding mode predictions of ligands in Cyt P450 crystal structures in an earlier study (de Graaf et al. J. Med. Chem. 2005, 7, 2308-2318) were used for the catalytic site prediction (CSP) of 65 Substrates in a CYP2D6 homology model. The consideration of water molecules at predicted positions in the active site and the rescoring of pooled docking poses from four different docking programs (AUtoDock, FlexX, GOLD-Goldscore, and GOLD-Chemscore) with the SCORE scoring function enabled the successful prediction of experimentally reported sites of catalysis of more than 80% of the substrates. Three docking algorithms (FlexX, GOLD-Goldscore, and GOLD-Chemscore) were subsequently used in combination with six scoring functions (Chemscore, DOCK, FlexX, GOLD, PMF, and SCORE) to assess the ability of docking-based virtual screening methods to prioritize known CYP2D6 substrates seeded into a drug-like chemical database (in the absence and presence of active-site water molecules). Finally, the optimal docking strategy in terms of virtual screening accuracy, GOLD-Chemscore with the consideration of active-site water (60% of known substrates recovered in the top 5% of the ranked drug-like database), was verified experimentally; it was successfully used to identify high-affinity CYP2D6 ligands among a larger proprietary database.
引用
收藏
页码:2417 / 2430
页数:14
相关论文
共 86 条
[1]   Virtual screening of 4-anilinoquinazoline analogues as EGFR kinase inhibitors: Importance of hydrogen bonds in the evaluation of poses and scoring functions [J].
Aparna, V ;
Rambabu, G ;
Panigrahi, SK ;
Sarma, JARP ;
Desiraju, GR .
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2005, 45 (03) :725-738
[2]   Docking studies on PARP-1 inhibitors: insights into the role of a binding pocket water molecule [J].
Bellocchi, D ;
Macchiarulo, A ;
Costantino, G ;
Pellicciari, R .
BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) :1151-1157
[3]   Molecular genetics of CYP2D6:: Clinical relevance with focus on psychotropic drugs [J].
Bertilsson, L ;
Dahl, ML ;
Dalén, P ;
Al-Shurbaji, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 53 (02) :111-122
[4]   Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase [J].
Birch, L ;
Murray, CW ;
Hartshorn, MJ ;
Tickle, IJ ;
Verdonk, ML .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2002, 16 (12) :855-869
[5]   Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations [J].
Bissantz, C ;
Folkers, G ;
Rognan, D .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (25) :4759-4767
[6]   LUDI - RULE-BASED AUTOMATIC DESIGN OF NEW SUBSTITUENTS FOR ENZYME-INHIBITOR LEADS [J].
BOHM, HJ .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 1992, 6 (06) :593-606
[7]   Comparative study of several algorithms for flexible ligand docking [J].
Bursulaya, BD ;
Totrov, M ;
Abagyan, R ;
Brooks, CL .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2003, 17 (11) :755-763
[8]   Consensus scoring for ligand/protein interactions [J].
Clark, RD ;
Strizhev, A ;
Leonard, JM ;
Blake, JF ;
Matthew, JB .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2002, 20 (04) :281-295
[9]  
COLE JC, 2005, PROTEINS
[10]   Keynote review: Structural biology and drug discovery [J].
Congreve, M ;
Murray, CW ;
Blundell, TL .
DRUG DISCOVERY TODAY, 2005, 10 (13) :895-907